This is the official website for the Reglan/Metoclopramide Settlement Program (“Reglan/MCP Settlement Program”), a private settlement program governed by the Master Settlement Agreements (MSAs) of Schwarz Pharma, Inc. n/k/a UCB, Inc. and Generics International, Inc. 

The Reglan/MCP Program is now open for the submission of Registration information. To submit Registration information for one or more Reglan/MCP Users, click the button below or go to the Portal menu item above to access the Program’s secure Reglan/MCP Portal and follow the instructions there.